MarkRapaportMD

PubMed

• Biological Insights from Schizophrenia-associated Loci in Ancestral Populations.
  Tim B Bigdeli, Chris Chatzinakos, Jaroslav Bendl, Peter B Barr, Sanan Venkatesh
  Medrxiv. 2024-08-28
• A Patient-Centered Multidisciplinary Medical HOME for Persons With Intellectual and Developmental Disabilities.
  Patricia Aguayo, Anne G Lin, Paul T Stevens, Paul S Carbone, Deborah A Bilder
  Focus. 2024-04-01
• 2 citations
  Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive func...
  Naoise Mac Giollabhui, David Mischoulon, Boadie W Dunlop, Becky Kinkead, Pamela J Schettler
  Brain, Behavior, & Immunity - Health. 2023-10-01

Journal Articles

• Insomnia and Suicidal Ideation in Non-Affective Psychosis  
  Brian J Miller, Mark H Rapaport, Peter F Buckley, Sleep

Books/Book Chapters

• Psychiatry, 
  Chapter: "Anxiolytic Drugs" 
  Saah TC, Garlow SJ, Rapaport MH, Edwards DM, Hale KL, Maddux, REEditors: A Tasman, J Kay, J Lieberman, M First and M Maj.John Wiley & Sons, Ltd.Edition 4th,2014
• FOCUS, Maintenance of Certification (MOC) Workbook 
  Chapter: "Major Depressive Disorder" 
  Hales DJ, Rapaport MH, Moeller KAPPI Press2013
• Child Adolesc Psychiatric Clin N Am 
  Chapter: "Building an Evidence Base in Complementary and Integrative Healthcare for Child & Adolescent Psychiatry" 
  Page 509 - 529Edwards E, Mischoulon D, Rapaport MH, Stussman B, Weber WElsevier, Inc.2013
• FOCUS, Psychiatry Review 
  Chapter: "400 All New Multiple Choice Questions." 
  Hales DJ, Rapaport MHAPPI Press2011
• The American College of Neuropsycho Pharmacology Textbook of Psychopharmacology 
  Chapter: "Treatment of Depression." 
  Page 1081 - 1111Bresee CJ, Gotto J, Rapaport MHEditors: Schatzberg AF, Nemeroff CB.APPIEdition Four,2009
• FOCUS, Psychiatry Review 
  Chapter: "400 Self-Assessment Questions." 
  Hales DJ, Rapaport MHAPPI Press2007
• Mood and Anxiety Disorders 
  Chapter: "Quality of life impairment in anxiety disorders." 
  Page 275 - 291Koury MA, Rapaport MHEditors: M.S.Ritsner and A.G. Awad.Springer2007
• World Psychiatric Association: Evidence and Experience in Psychiatry 
  Chapter: "Burden of phobias: Focus on health-related quality of life." 
  Rapaport MH, Delrahim KK, Maddux REJohn Wiley & Sons Ltd., London2004
• Handbook of Chronic Depression: Diagnoses and Therapeutic Management 
  Chapter: "Psychopharmacology and psychotherapy of subsyndromal depressions." 
  Page 183 - 206Maddux RE, Rapaport MHEditors: Alpert, Fava.Marcel Dekker2004
• Psychiatry 
  Chapter: "Anxiolytic Drugs." 
  Page 2033 - 2049Maddux RE, Rapaport MHEditors: Tasman A, Kay J, Lieberman J.Wiley & SonsEdition Seco,2003
• Psychiatric Clinics of North America 
  Chapter: "Anxiety Disorders." 
  Page 181 - 208Barrett C, Rapaport MH2001
• Psychoneuroimmunology 
  Chapter: "Immunological states associated with schizophrenia." 
  Page 373 - 382Rapaport MH, Muller NEditors: Ader, Felten, Cohen.Edition Thir,2001
• Psychiatry, Psychoimmunology, and Viruse 
  Chapter: "A preliminary analysis investigating immune activation in schizophrenia." 
  Page 101 - 114Rapaport MH, Caliguiri M, Lohr JB, Dolnak D, Chavez S, Kulesh C, Hahn TEditors: Muller N.1999
• Basic and Clinical Science of Mental and Addictive Disorders 
  Chapter: "The role of subsyndromal depressive symptoms in unipolar major depression." 
  Page 6 - 10Judd LL, Paulus M, Akiskal HS, Rapaport MH, Kunovac JLEditors: Judd LL, Saletu B, and Filip V.Karger Press, Basel, Switzerland1997
• Excerpta Medica IX World Congress of Psychiatry 
  Chapter: "New subtypes of depression: implications for research." 
  Rapaport MH, Judd LLElsevier Press1994
• Exerpta Medica VIII World Congress of Psychiatry 
  Chapter: "Immunological findings in schizophrenia." 
  Rapaport MHElsevier1991
• Schizophrenia 
  Chapter: "The role of autoimmunity in schizophrenia." 
  McAllister CG, Rapaport MH, Paul SMEditors: Schultz and Tamminga.Raven Press1991
• Psychoimmunology Updates 
  Chapter: "Neuroimmunological factor in schizophrenia." 
  Page 31 - 54Rapaport MH, McAllister CGEditors: Gorman and Kertzner.Amer Psych Press1991
• Augmentation Strategies for Treatment Refractory Schizophrenic Patients 
  Chapter: Benzodiazepine augmentation of neuroleptics 
  Wolkowitz OM, Rapaport MH, Pickar DEditors: Schultz and Angrist.Amer Psych Press, Washington, DC1990
• Amer Psych Assoc Annual Update 
  Chapter: "The neurobiology of sleep: basic concepts and clinical implications." 
  Shiromani P, Rapaport MH, Gillin JCEditors: Hales and France.Washington, DC1987
• The American College Neuropsychopharmacology Textbook of Psychopharmacology 
  Chapter: "Treatment of Depression" 
  Shaywitz J, Rapaport MHEditors: Schatzberg AF, Nemeroff CB.APPIEdition Fift,
• Join now to see all

Abstracts/Posters

• "Inflammation, Depression and N-3 Fatty Acids: A Case of Personalized Medicine"
  Rapaport MH, Schettler PJ, Pace TW, Kinkead B, Nierenberg AA, Mischoulon D, ACNP 52nd Annual Meeting, Hollywood, FL, 1/1/2013
• "Innovations in Lifelong Learning for Psychiatrists: The Focus System"
  Rapaport MH, Hales D, Moeller K, 52nd Annual NCDEU Meeting, Phoenix, AZ, 1/1/2012
• "The Efficacy of Memantine for Cognitive Deficits in Euthymic Subjects with Bipolar Disorder"
  Isofescu D, Gilmer W, Fan A, Gonenc A, Moore C, Randolph C, Rapaport MH, Deckersbach T, and Nierenberg A, 52nd Annual NCDEU Meeting, Phoenix, AZ, 1/1/2012
• "The Efficacy of the Glutamate NMDA Receptor Antagonist Memantine for Cognitive Deficits in Euthymic Subjects with Bipolar Disorder"
  Iosifescu D, Gilmer W, Fan A, Gonenc A, Moore C, Randolph C, Rapaport MH, Deckersbach T, and Nirenberg A, ACNP 51st Annual Meeting, Hollywood, FL, 1/1/2012
• "Use of Audio-Digital Recordings for External Monitoring to Improve Subject Selection in a Schizophrenia Trial."
  Rapaport MH, Little J, Ereshefsky L, Demartinis N, Targum S, 51st Annual NCDEU Meeting, Boca Raton, FL, 1/1/2011
• "Treating Major Depressive Disorder by Creating Positive Expectations for the Future: A Study for the Efficacy of Future Directed Therapy (FDT)"
  Rapaport, MH, 51st Annual NCDEU Meeting, Boca Raton, FL, 1/1/2011
• "The Biology of Massage: Implications for Psychiatry."
  Rapaport MH, Bresee C, Schettler P, ACNP 49th Annual Meeting, Miami Beach, FL, 1/1/2010
• "Compound Identified by Neurogenesis Platform Shows Promising Efficacy in Treatment of Patients with Major Depressive Disorder with Concomitant Generalized Anxiety Dis...
  Wedel PC, Barlow C, Bleicher LS, Carter TA, Dearie AR, Defratis-robinson J, Drayer JI, Lee DM, Lorrain KI, Pires JC, Rapaport MH, Seehus CR, Schettler PJ, Stoveken BS,..., Society of Neuroscience, 40th Annual Meeting, San Diego, CA, 1/1/2010
• "Use of a Relapse Monitoring Board for Independent Assessment of the Primary End Point in an International Clinical Trial of Bipolar Disorder."
  Turner N, Macfadden W, Anand R, Khanna S, Rapaport MH, Haskins T, Turkoz I, Alphs L, ISCTM Annual Meeting, 1/1/2009
• "Quality of Life in Major Depressive Disorder in a Naturalistic Treatment Setting."
  IsHak WW, Rapaport MH, 49th Annual NCDEU Meeting, 1/1/2009
• "Assessment of the Maximum Tolerated Dose (MTD) of Lurasidone in Patients with Schizophrenia."
  Ereshefsky L, Jhee S, Phillips D, Peterson M, Ogasa M, Gertsik, Loebel A, Rapaport MH, ACNP 48th Annual Meeting, Hollywood, FL, 1/1/2009
• "Quality of Life of Patients with Major Depression in a Natural Clinical Setting"
  Rapaport MH, IsHak WW, FOCUS Live Session, APA Annual Meeting, Washington, DC, 1/1/2008
• "The Role of Oxytocin, Vasopressin and Cortisol in the Beneficial Effects of Massage."
  Rapaport MH, Hale KL, Koury MA, Shubov A, Bresee KJ, Society of Biological Psychiatry, 1/1/2008
• "The Beneficial Effects of Massage Therapy on Psychiatric and Biological Measures."
  Rapaport MH, Koury MA, Hale KL, Bresee KJ, Society of Biological Psychiatry 62nd Annual Scientific Convention and Meeting, 1/1/2007
• "The Effects of Acute and Continuous Massage Therapy on the HPA Axis and Immune Function."
  Rapaport MH, Bresee KJ, American College of Neuropsychopharmacology, 1/1/2007
• "Cytokine Alterations in Medication-Stabilized Patients with Schizophrenia."
  Rapaport MH, Bresee K, Society for Biological Psychiatry 61st Annual Meeting, 1/1/2006
• "A New Approach for Assessing Patients with Generalized Anxiety Disorder or Major Depression and Residual Symptoms."
  Anand R, Gharabawi G, Greist J, Rapaport MH, Sheehan D, American Psychiatric Association 159th Annual Meeting, 1/1/2006
• "Clinical Psychopharmacology and Neurosciences: Keeping-up by Tailoring the Curriculum to the Constituency."
  Glick ID, Rapaport MH, Ketter TA, Zisook S, NCDEU, 1/1/2006
• "Efficacy and Safety of Bifeprunox versus Placebo in the Treatment of Patients with Acute Exacerbations of Schizophrenia."
  Rapaport MH, Barbato LM, Heisterberg J, Yeung PP, Shapiro NA, American College of Neuropsychopharmacology 45th Annual Meeting, 1/1/2006
• "COX-2 Inhibitor Augmentation Therapy for Schizophrenia."
  Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Risperidone Augmentation of Treatment-Resistant Depression: Brain Metabolite Alterations Associated with Treatment Response"
  Gertsik L, Moser F, Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Fluoxetine Not Found to Increase Suicidality Over Placebo During Treatment of Adults with Minor Depressive Disorder."
  Thase ME, Rush JA, Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Clinical Characteristics of Patients With Minor Depression."
  Howland RH, Nierenberg A, Rapaport MH, APA, 1/1/2005
• "Treatment Augmentation with Risperidone for Patients with Resistant Depression."
  Rapaport MH, Canuso CM, Rouillon F, Leblanc J, Young AH, Loescher A, Bossie CA, Turkoz I, Gharabawi GM, and the ARISe-RD Study Group, APA, 1/1/2004
• "Improvement in Quality of Life with Risperidone Augmentation in Resistant Depression."
  Walling D, Rapaport MH, Rupnow MFT, Canuso CM, Gharabawi GM, APA, 1/1/2004
• Join now to see all

Lectures

• Grand Rounds: "Inflammation, Depression, Omega-3 Fatty Acids: A Proof of Concept" 
  UCLA Semel Institute, Los Angeles, CA - 1/1/2014
• "Immunotherapeutic approaches for the treatment of depression" 
  Kyoto, Japan - 1/1/2013
• Workshop 69: "ABPN and APA Perspectives on "Maintenance of Certification" 
  San Francisco, CA - 1/1/2013
• NCDEU NIA Program Panel Discussion, "Extramural Perspective" 
  Hollywood, FL - 1/1/2013
• NCDEU NIA Program, "Getting a Job and Keeping It? 
  Hollywood, FL - 1/1/2013
• Panel Presentation: "How does Massage Work? Potential Mechanisms" 
  Massage Therapy Foundation, Boston, MA - 1/1/2013
• "Maintenance of Certification Workshop" 
  Atlanta, GA - 1/1/2013
• FOCUS "Major Depressive Disorder Maintenance of Certification (MOC) Workbook", Small Interactive Sessions 
  San Francisco, CA - 1/1/2013
• "Residual Symptoms in Depression: Management and Prognosis" 
  Shanghai Mental Health Center, Shanghai, PR China - 1/1/2012
• Symposium "Psychoneuroimmunology in the Service of Personalized Medicine in Psychiatry" 
  Prague, Czech Republic - 1/1/2012
• Mental Health Lecture Series, "A Review of CAM Treatments for Mood and Anxiety Disorders, the Good, the Bad and the Ugly" 
  School of Public Health, Emory University, Atlanta, GA - 1/1/2012
• "Mood Disorders" 
  The Carter Center, Atlanta, GA - 1/1/2012
• Special Session: "Innovations in Life Long Learning for Psychiatrists: The Focus System" 
  Phoenix, AZ - 1/1/2012
• "CAM: Implications for Mood & Anxiety Disorders" 
  Philadelphia, PA - 1/1/2012
• "Bipolar Spectrum Disorders: Underdiagnosed? Over-diagnosed? Strategies for Treatment" 
  1/1/2012
• "Off the Couch: Why Atlanta Can Transform Psychiatry in the 21st Century" 
  Skyland Trail, Atlanta, GA - 1/1/2011
• "Complementary and Alternative Medicine" 
  Toronto, Canada - 1/1/2011
• "Grant Writing Workshop for Complementary and Integrative Medicine" 
  Toronto, Canada - 1/1/2011
• "Major Depressive disorder: Where are We Going?" 
  Las Vegas, NV - 1/1/2011
• "Diagnosis and Treatment of Bipolar Disorder" 
  Tucson, AZ - 1/1/2011
• Grand Rounds: "Complementary and Alternative Therapies for Mood and Anxiety Disorders: The Good, the Bad, and the Ugly" 
  Georgia Health University, Augusta, GA - 1/1/2011
• "Psychopharmacology for Depression and Mood Disorders: Tips for Success" 
  Atlanta, GA - 1/1/2011
• Case Presentation: "What Next? A case Presentation of Treatment Resistant Depression" 
  Atlanta, GA - 1/1/2011
• Round Table Discussion: "Immunology and Psychiatry" 
  Munich, Germany - 1/1/2010
• "Immune Sequelae in Schizophrenia: the Quest for Testable Hypotheses" 
  Munich, Germany - 1/1/2010
• Join now to see all

Other

• "A placebo-controlled study of topiramate in acute mania (bipolar I disorder): Trials and tribulations of conducting an acute mania study." 
  Van Kammen DP, Chengappa KNR, Shiwach R, Lesem M, Wang D, Topamax Psychiatry Phase II Study Group
  1/1/2003
• "Case history: major depressive disorder in a middle-aged female" 
  Zisook S, Rapaport MH
  Medical Age Publishing, Norwalk, CT - 1/1/1997